Method: ICP-MS (Inductively Coupled Plasma Mass Spectrometry) with creatinine normalization by Jaffe Reaction (CLIA 14D0646470); not cleared or approved by the FDA. Results in µg/g creatinine; reference intervals based on NHANES population data under non-provoked conditions. Not a stand-alone diagnosis; should be interpreted in clinical context.

Beryllium is a lightweight metal found in certain rocks and minerals with no biological role in humans.

Key benefits of Beryllium (Be) testing

  • Beryllium occupational and industrial exposure tracking
  • rare but highly toxic metal monitoring

What is Beryllium (Be)?

Beryllium is a rare, lightweight metal used in aerospace, nuclear, and electronics industries. Non-occupational exposure is uncommon. Urinary beryllium is primarily a marker of occupational or industrial exposure. Measured via ICP-MS.

Why is Beryllium (Be) important?

Beryllium is classified as a known human carcinogen (per IARC and NIOSH). Sensitized individuals may develop chronic beryllium disease upon re-exposure - a condition that warrants occupational medical evaluation. Even low-level occupational beryllium exposure warrants monitoring. Detection in non-occupationally exposed individuals is rare.

What insights will I get?

Your beryllium level may indicate occupational or industrial exposure. Detectable beryllium in non-industrial contexts may reflect environmental contamination. Discuss any elevated finding with your care team.

Similar biomarker tests from Superpower